Bg pattern

MEIACT 400 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEIACT 400 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

MEIACT 400 mg film-coated tablets

cefditoren

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the package leaflet

  1. What MEIACT 400 mg film-coated tablets are and what they are used for
  2. What you need to know before taking MEIACT 400 mg film-coated tablets
  3. How to take MEIACT 400 mg film-coated tablets
  4. Possible side effects
  5. Storage of MEIACT 400 mg film-coated tablets

Contents of the pack and additional information

1. What MEIACT 400 mg film-coated tablets are and what they are used for

MEIACT belongs to a group of antibiotics called cephalosporins, which work by inhibiting the synthesis of the bacterial cell wall.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or common cold.

It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw away medications down the drain or in the trash.

MEIACT is used in adult patients for the treatment of moderate community-acquired pneumonia.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking MEIACT 400 mg film-coated tablets

Do not take MEIACT

  • if you are allergic to antibiotics, particularly penicillin or other beta-lactam antibiotics, or to any of the other components of this medication (listed in section 6).
  • if you have a casein allergy, you should be aware that this medication contains sodium caseinate.
  • if you have a condition called primary carnitine deficiency.

Warnings and precautions

Consult your doctor or pharmacist before starting to take MEIACT

  • if you have liver and/or kidney disease
  • if you are receiving anticoagulant therapy
  • if you have a history of gastrointestinal disease, particularly colitis
  • if you are receiving treatment with nephrotoxic agents such as aminoglycoside antibiotics or potent diuretics (such as furosemide), as these combinations may have undesirable effects on renal function and have been associated with ototoxicity.

Consult your doctor if you experience any of the following effects during treatment:

  • if you experience an allergic reaction characterized by symptoms such as itching, redness, skin rash, swelling, or difficulty breathing during treatment
  • if you experience diarrhea while taking this medication or after completing treatment

As with other antibiotics, prolonged treatment with MEIACT may lead to an overgrowth of non-susceptible microorganisms, requiring discontinuation of treatment and institution of appropriate therapy.

Treatment with MEIACT may interfere with the results of some laboratory tests, potentially leading to false positives in:

  • Direct Coombs test
  • Urinary glucose determination

And false negatives in:

  • Blood or plasma glucose determination

Other medications and MEIACT

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

A minimum period of 2 hours should be allowed between the administration of antacids and MEIACT.

Concomitant administration of MEIACT with probenecid increases the amount of cefditoren in the blood.

Concomitant administration of MEIACT with intravenous famotidine is not recommended, as it may hinder the achievement of the necessary amount in the blood.

Pregnancy and lactation

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

MEIACT is not recommended during pregnancy or breastfeeding.

Driving and using machines

MEIACT may cause dizziness and drowsiness, which may affect your ability to drive or operate any tool or machine.

MEIACT 400 mg film-coated tablets contain sodium

This medication contains 26.2 mg of sodium (main component of table salt) per tablet. This is equivalent to 1.3% of the maximum recommended daily sodium intake for an adult.

3. How to take MEIACT 400 mg film-coated tablets

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again. Remember to take your medication. Your doctor will indicate the duration of treatment with MEIACT.

Swallow the tablets whole, with a sufficient amount of liquid (a glass of water), during meals.

The recommended dose of the medication and the frequency of administration are as follows:

Adults and adolescents (over 12 years)

1 tablet (400 mg of cefditoren) every 12 hours for 14 days is recommended.

Use in children under 12 years

The use of MEIACT has not been studied in patients under 12 years, and therefore, its administration is not recommended.

Elderly patients

No dose adjustments are necessary in elderly patients, except in cases of advanced hepatic and/or renal impairment.

Patients with renal impairment

No dose adjustment is necessary in patients with mild renal impairment. In patients with moderate renal impairment, do not exceed the dose of 200 mg of cefditoren (MEIACT 200 mg) every 12 hours. In patients with severe renal impairment, a single dose of 200 mg of cefditoren (MEIACT 200 mg) per day is recommended. The appropriate dose has not been determined in patients undergoing dialysis.

Patients with hepatic impairment

In mild or moderate hepatic impairment, it is not necessary to modify the treatment regimen. In cases of severe hepatic impairment, there are no data available to make a dose recommendation.

If you take more MEIACT than you should

If you have taken more MEIACT than recommended, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to take the packaging and package leaflet of the medication to the healthcare professional.

If you forget to take MEIACT

In case you have forgotten a dose, take another as soon as possible and continue with the usual schedule. Do not take a double dose to make up for forgotten doses.

If you stop treatment with MEIACT

Do not stop treatment before the duration indicated by your doctor, as there is a risk of relapse of the disease.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them. Side effects may occur mainly of a gastrointestinal nature.

Very common (more than 1 in 10 people):

  • diarrhea

Common (1 to 10 in 100 people):

  • headache, nausea, abdominal pain, feeling of indigestion, and vaginal infection

Uncommon (1 to 10 in 1,000 people):

  • fungal infection
  • anorexia
  • nervousness, dizziness, and sleep disorders
  • pharyngitis, rhinitis, and sinusitis
  • constipation, flatulence, vomiting, oral candidiasis, eructation, dry mouth, and loss of taste
  • liver function alterations
  • skin rash, itching, and urticaria
  • vaginal inflammation and vaginal discharge
  • fever, weakness, and sweating
  • alterations in blood cell counts (leukopenia and thrombocytosis), liver function test disorders (elevated ALT)

Rare (1 to 10 in 10,000 people):

  • hemolytic anemia and lymph node alterations
  • dehydration
  • dementia, depersonalization, emotional weakness, euphoria, hallucinations, and increased libido
  • memory loss, discoordination, increased muscle tone, meningitis, and tremor
  • photosensitivity, visual acuity loss, eye pain, and eyelid inflammation
  • tinnitus
  • heart rhythm disorders, heart failure, and fainting
  • low blood pressure
  • asthma
  • oral ulcers, stomatitis, hemorrhagic colitis, ulcerative colitis, gastrointestinal bleeding, hiccups, tongue inflammation and discoloration, diarrhea associated with Clostridium difficile
  • acne, hair loss, eczema, exfoliative dermatitis (cracked and scaly skin), and herpes simplex
  • muscle pain
  • urination pain, kidney inflammation, alterations in urination frequency, incontinence, and urinary tract infection
  • breast pain, menstrual disorders, and erectile dysfunction
  • body odor and chills
  • alterations in blood cell counts (eosinophilia, neutropenia, thrombocytopenia), coagulation disorders (prolonged coagulation time, decreased thromboplastin time, platelet alterations), liver function test disorders (elevated AST, alkaline phosphatase), alterations in certain blood components (hyperglycemia, hypokalemia, bilirubinemia, elevated LDH, hypoproteinemia, elevated creatinine), or urine (albuminuria)

Frequency not known:

  • pneumonia
  • Stevens-Johnson syndrome (blisters and erosion of the skin and mucous membranes)
  • skin redness
  • toxic epidermal necrolysis (severe form of Stevens-Johnson syndrome followed by skin pain and shedding of the upper layer of the skin)
  • acute kidney failure
  • anaphylactic shock
  • serum sickness-like reaction (late allergic reaction of the skin)
  • decrease in blood cell counts (agranulocytosis)
  • decrease in carnitine levels in the blood
  • cholestasis (obstruction of bile flow from the liver)
  • aplastic anemia (decrease in blood cell counts)
  • liver damage
  • hepatitis

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of MEIACT 400 mg film-coated tablets

Keep this medication out of the sight and reach of children.

Store in the original packaging.

Do not store above 30°C.

Do not use this medication after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and additional information

Composition of MEIACT 400 mg film-coated tablets
  • The active ingredient is cefditoren. Each tablet contains 400 mg of cefditoren (as cefditoren pivoxil).
    • Other components are:

core: sodium caseinate, sodium croscarmellose, mannitol E-421, sodium tripolyphosphate, and magnesium stearate.

coating: Opadry Y-1-7000 (hypromellose, titanium dioxide E-171, macrogol 400) and carnauba wax.

Opacode S-1-20986 blue printing ink: shellac, brilliant blue lake, titanium dioxide E-171, propylene glycol, and concentrated ammonia solution.

Appearance of the product and pack contents

MEIACT 400 mg is presented in the form of film-coated tablets. Each pack contains 10 tablets.

Other presentations

MEIACT 200 mg film-coated tablets: each pack contains 16 or 20 tablets.

Marketing authorization holder and manufacturer:

Meiji Pharma Spain, S.A.

Avenida de Madrid, 94

28802 Alcalá de Henares, Madrid (Spain)

Date of the last revision of this package leaflet: November 2020

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es

Online doctors for MEIACT 400 mg FILM-COATED TABLETS

Discuss questions about MEIACT 400 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for MEIACT 400 mg FILM-COATED TABLETS?
MEIACT 400 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEIACT 400 mg FILM-COATED TABLETS?
The active ingredient in MEIACT 400 mg FILM-COATED TABLETS is cefditoren. This information helps identify medicines with the same composition but different brand names.
How much does MEIACT 400 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for MEIACT 400 mg FILM-COATED TABLETS is around 40.01 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MEIACT 400 mg FILM-COATED TABLETS?
MEIACT 400 mg FILM-COATED TABLETS is manufactured by Meiji Pharma Spain S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEIACT 400 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEIACT 400 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEIACT 400 mg FILM-COATED TABLETS?
Other medicines with the same active substance (cefditoren) include MEIACT 200 mg FILM-COATED TABLETS, SPECTRACEF 200 mg FILM-COATED TABLETS, SPECTRACEF 400 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media